Device / Technology News

RSS

Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator

Sorin Group, a global leader in the treatment of cardiovascular disease, announced today U.S. FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym™ CRT Model 8750. Featuring a new, state-of-the-art battery technology, Paradym™ CRT delivers 37 Joules, the highest energy of any implantable cardiac defibrillator (ICD) currently available.

6 Feb 2010

FDA's issues guidance on Bayesian statistical methods in medical device clinical trials

The U.S. Food and Drug Administration today issued guidance on Bayesian statistical methods in the design and analysis of medical device clinical trials that could result in less costly and more efficient patient studies.

6 Feb 2010

Novus Scientific's TIGR Matrix Surgical Mesh receives FDA marketing approval

Novus Scientific Pte. Ltd today announced that the US Food and Drug Administration (FDA) has given the company 510(k) clearance to market the TIGR™ Matrix Surgical Mesh, for use in reinforcement of soft tissues where weakness exists. TIGR™ Matrix Surgical Mesh is a 100 percent resorbable, synthetic matrix, knitted from two different resorbable fibers that degrade at different rates following implantation.

5 Feb 2010

Radiation oncologists push for safety standards

The New York Times: "The leading professional organization dedicated to radiation oncology has called for enhanced safety measures in administering medical radiation, including the establishment of the nation's first central database for the reporting of errors involving linear accelerators — machines that generate radiation — and CT scanners.

5 Feb 2010

Epocrates' clinical reference application to be customized for new iPad computer tablet

Epocrates, Inc., today announced its top-ranked clinical reference application for the iPhone® and iPod® touch devices will be customized for the new iPad™ computer tablet. The iPad is already receiving a warm reception from the healthcare industry with nearly 20 percent of clinicians expressing plans to purchase in an Epocrates survey conducted days after the Apple announcement.

5 Feb 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Estimates of pain care treatment costs exceed $1 billion annually in the United States. Today at the American Academy of Pain Medicine's 26th Annual Meeting two abstracts looked at the issue. One evaluated intrathecal drug delivery (a targeted medicine delivery system) that could save costs over time. The other analyzed the differences between the costs of treatment for chronic pain treatments.

5 Feb 2010

Jerry Hill and Nathan Fletcher receive CHI Advancing California Biomedical Research and Innovation Award

CHI-California Healthcare Institute, a non-profit public policy research organization, honored Assembly Members Jerry Hill (D-San Mateo) and Nathan Fletcher (R-San Diego) with the CHI Advancing California Biomedical Research and Innovation Award at a biomedical industry dinner on Feb. 2 in Sacramento.

5 Feb 2010

NIH panel convened to increase the use and quality of colorectal cancer screening in the U.S.

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical.

5 Feb 2010

Humana Military introduces first-ever online community center for military families

Humana Military Healthcare Services, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), proudly announces the launch of TRIWORLD, a first-ever online virtual world designed exclusively for military families.

5 Feb 2010

Low frequency therapy for temporary tinnitus: Student research project evolves into web-based company

In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.

5 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

A comprehensive study of the components of the delivery of modern-day cancer care in community oncology practices revealed that Medicare covers only 56% of the actual costs of administering chemotherapy and providing related infusion room services to seniors with cancer. The remaining costs -- for essential services provided such as treatment planning, care coordination, and follow-up care planning -- are not reimbursed by Medicare, causing many oncology practices to struggle to continue to provide care under the Medicare program.

5 Feb 2010

Results validating performance of GSN’s proprietary Parental Support technology published

Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN’s proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF).

5 Feb 2010

New England Biolabs to supply Wellcome Trust Sanger Institute next-generation sequencing library construction reagents

As an important supplier to the Wellcome Trust Sanger Institute, New England Biolabs is pleased to announce that the Sanger Institute will use New England Biolabs as one of its suppliers for next-generation sequencing library construction reagents.

From New England Biolabs 5 Feb 2010

Non-invasive MR Spectroscopy to determine ability to be fathers

Men with no sperm in their ejaculate—a condition known as azoospermia—may no longer need invasive procedures to determine if they have sperm in their testes according to a new study published in Human Reproduction.

5 Feb 2010

World Heart consortium awarded $5.6M NIH contract for developing PediaFlow VAD

World Heart Corporation ("WorldHeart") announced today that it was part of a consortium awarded a $5.6 million, 4-year contract by the National Institutes of Health (NIH) to further develop the PediaFlow™ VAD to clinical trial readiness.

5 Feb 2010

Physmark introduces HealthKeys for preventive care programs

Physmark has announced HealthKeys, a software system and service based on the company's patent-pending cost model that measures the effectiveness and cost savings of preventive care programs.

5 Feb 2010

Implanted ventricular assist heart pump for infants project awarded $5.6M federal contract

Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.

5 Feb 2010

SIS RBC solution meets the stringent standards of Peer Review program

For the third consecutive year, the Healthcare Financial Management Association (HFMA) performed a rigorous assessment of SIS Rules-Based Charging (RBC), an automated charge capture solution by Surgical Information Systems, and determined that it meets the stringent standards of the Peer Review program in the areas of effectiveness, quality and usability, price, value, and customer and technical support.

5 Feb 2010

CCHP implements TriZetto systems to improve its network and health management programs

The TriZetto Group, Inc. today announced that Chinese Community Health Plan (CCHP) has successfully implemented several TriZetto systems, including the Facets®, NetworX Pricer® and Clinical CareAdvance® applications.

5 Feb 2010

Device / Technology News

Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator

FDA's issues guidance on Bayesian statistical methods in medical device clinical trials

Novus Scientific's TIGR Matrix Surgical Mesh receives FDA marketing approval

Radiation oncologists push for safety standards

Epocrates' clinical reference application to be customized for new iPad computer tablet

Intrathecal drug delivery cost effective for chronic pain treatments

Jerry Hill and Nathan Fletcher receive CHI Advancing California Biomedical Research and Innovation Award

NIH panel convened to increase the use and quality of colorectal cancer screening in the U.S.

Humana Military introduces first-ever online community center for military families

Low frequency therapy for temporary tinnitus: Student research project evolves into web-based company

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

Results validating performance of GSN’s proprietary Parental Support technology published

New England Biolabs to supply Wellcome Trust Sanger Institute next-generation sequencing library construction reagents

Non-invasive MR Spectroscopy to determine ability to be fathers

World Heart consortium awarded $5.6M NIH contract for developing PediaFlow VAD

Physmark introduces HealthKeys for preventive care programs

Implanted ventricular assist heart pump for infants project awarded $5.6M federal contract

SIS RBC solution meets the stringent standards of Peer Review program

CCHP implements TriZetto systems to improve its network and health management programs

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News